Aadi Bioscience Shares Are Trading Lower After the Company Announced an Analysis by the Independent Data Monitoring Committee Demonstrated That the Study Was Unlikely to Exceed an Efficacy Threshold Necessary to Support an Accelerated Approval. The...

Benzinga · Aug 21 19:58

Aadi Bioscience Shares Are Trading Lower After the Company Announced an Analysis by the Independent Data Monitoring Committee Demonstrated That the Study Was Unlikely to Exceed an Efficacy Threshold Necessary to Support an Accelerated Approval. The Company Will Pause New Enrollment and Is Reducing Its Research & Development Workforce by 80%.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Aadi Bioscience Shares Are Trading Lower After the Company Announced an Analysis by the Independent Data Monitoring Committee Demonstrated That the Study Was Unlikely to Exceed an Efficacy Threshold Necessary to Support an Accelerated Approval. The...

Risk Disclaimer